In the rapidly evolving world of biotechnology, AnPac Bio-Medical Science Co., Ltd. has emerged as a company that is making significant strides in its field. Based in Lishui in the People's Republic of China, the company was incorporated in 2010 and has since established a reputation for being a leading player in the market for multi-cancer screening and detection tests. Using its state-of-the-art cancer differentiation analysis technology and device, AnPac Bio-Medical Science Co., Ltd. has attracted strong interest from corporations and life insurance companies in China. Its services are highly sought after for their accuracy and reliability in detecting cancer at an early stage. In addition to its cancer screening and detection tests, AnPac Bio-Medical Science Co., Ltd. provides physical checkup package services that have become increasingly popular. With its focus on cutting-edge research and development, the company is well positioned to continue its remarkable growth trajectory in the years ahead.
AnPac Bio-Medical Science Co., Ltd.'s ticker is ANPC
The company's shares trade on the NASDAQ stock exchange
They are based in Lishui, China
There are 51-200 employees working at AnPac Bio-Medical Science Co., Ltd.
It is https://www.anpacbio.com/
AnPac Bio-Medical Science Co., Ltd. is in the Healthcare sector
AnPac Bio-Medical Science Co., Ltd. is in the Biotechnology industry
The following five companies are AnPac Bio-Medical Science Co., Ltd.'s industry peers: